Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis Clinical research trials and Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis. Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis clinical trial. Test subjects typically receive the most effective healthcare possible for their Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.

Home > "S" Clinical Trials Conditions > Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis

Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis



Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis

For Condition: Cystic Fibrosis
Status: Recruiting
Sponsor(s): National Center for Research Resources (NCRR) , Indiana University
Synopsis: OBJECTIVES: I. Compare the resting energy expenditure using respiratory calorimetry in infants and children with moderate to severe cystic fibrosis versus age matched healthy controls. II. Determine the total energy expenditure and energy spent on physical activity using the doubly labeled water method in these patient populations.
Details: PROTOCOL OUTLINE: Patients and healthy controls receive an oral dose of doubly labeled water following initial urine collection on day 1. Patients undergo additional urine collection at 4-6 hours following doubly labeled water consumption and then daily for 7 days. Additionally, at the beginning of the study, patients and healthy controls undergo respiratory calorimetry over approximately 45 minutes at rest, starting approximately 2-3 hours after the last meal consumption and last use of aerosol bronchodilators (if required).
Eligibility:
Study Type:  Observational, Natural History
Minimum Age/Maximum Age: /10 Years
Genders: Both
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- - Diagnosis of cystic fibrosis (CF) by two positive sweat tests No exacerbations of present condition within past 2 months FEV1 less than 50% of predicted No other uncorrected lung disease No requirement for supplemental oxygen OR - Healthy (control group) Age matched to CF patients No preexisting lung disease Clinically well No hospitalizations within past 6 months --Prior/Concurrent Therapy-- - Concurrent pancreatic enzyme supplementation for CF required Clinically stable on current medications (CF patients) --Patient Characteristics-- - Age: Birth to 12 months 6 to 10 years - Cardiovascular: No major cardiovascular problems (CF patients) No preexisting heart disease (control group) - Pulmonary: See Disease Characteristics - Other: No chromosomal abnormalities (CF patients) No acute infection (CF patients) No diabetes mellitus (both groups)
Total Enrollment: 60

Location and Contact Information:

Overall Study Official:
CatherineLeitch,  Study Chair,  Indiana University

Indiana University *Recruiting*
Indianapolis,  Indiana,  46202-5167
United States
Recruiting Catherine  Leitch 317-274-4920


Additional Information:
Study ID Numbers:  NCRR-M01RR00750-9040;  IU-9509-20
Study Start Date: June 1996
Record last reviewed: December 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00006273

Other Cystic Fibrosis Studies:
1. Pressure support ventilation during CF exacerbations

2. Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis

3. Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa

4. Phase III Randomized Study of the Inhalation of Tobramycin in Patients with Cystic Fibrosis

5. Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis

Related Studies:

Other Cystic Fibrosis Clinical Trials
Other Indiana Clinical Trials
Other Indianapolis Clinical Trials

Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis
Modify your Search

  Other Cystic Fibrosis Clinical Trials
  Other Indiana Clinical Trials
  Other Indianapolis Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103